Status:
COMPLETED
Study to Identify Non-Invasive Markers of Gastrointestinal Allergy
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
TechLab, Incorporate
Conditions:
Esophagitis
Colitis
Eligibility:
All Genders
Up to 18 years
Brief Summary
The incidence of gastrointestinal allergy is on the rise and can be manifest in a number of different clinical presentations. The goal of this study is to evaluate the measurement of CD23, a protein t...
Detailed Description
The incidence of gastrointestinal allergy is on the rise and can be manifest in a number of different clinical presentations. The goal of this study is to evaluate the measurement of CD23, a protein t...
Eligibility Criteria
Inclusion
- Known or suspected cow milk protein intolerance Known or suspected eosinophilic esophagitis
Exclusion
- None
Key Trial Info
Start Date :
September 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00272818
Start Date
September 1 2004
End Date
December 1 2008
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital
Boston, Massachusetts, United States, 02115